ORIGINAL ARTICLEHow different is the dietary pattern in non-alcoholic steatohepatitis patients?
Introduction
Non-alcoholic steatohepatitis (NASH) is characterized by liver fat infiltration with various degrees of inflammation, necrosis and fibrosis, similar to alcoholic hepatitis in the absence of significant alcohol intake.1 In recent years, it became increasingly evident that fatty liver with necroinflammation (NASH) is part of a broader spectrum, non-alcoholic fatty liver disease (NAFLD), ranging from fatty liver to “cryptogenic” cirrhosis.2, 3, 4, 5
The primary forms of the disease, once drugs, toxins, or other causes are excluded, have often been associated with obesity, insulin resistance, and the metabolic syndrome.6, 7, 8 Despite the apparent links to metabolic disorders, the mechanisms of the disease are as yet poorly understood, and little is known about patient's diet history and its potential role in oxidative stress, thought to be involved in the progression to steatohepatitis.9, 10, 11, 12, 13, 14 Dietary factors, namely the type of fat, may indeed favour oxidative stress phenomena, and patient management usually includes diet modifications, despite the lack of supporting evidence.
Two recent studies on dietary intake of selected NAFLD patients disclosed dissimilar results; one reported saturated fat/cholesterol-rich diets yet poor in polyunsaturated fat, fibre, and vitamins C and E,15 whilst the other highlighted the association between higher carbohydrate intake with significantly higher odds of inflammation.16 So far, the pattern of dietary and nutrient intake in NASH remains scarcely evaluated and controversial.
Therefore, the aim of the present study conducted in non-selected patients with biopsy-proven NASH was to analyse their past diet and how it compared with data reported by common free-living subjects, frequency matched for sex and age, from the same geographical region; data analysis was adjusted for individual body mass index (BMI), in order to avoid potential bias associated with weight. Adequacy of patient's nutrient intake was further evaluated in function of recommended Dietary Reference Intakes (DRIs).
Section snippets
Patients
Between March and August 2004, 56 biopsy-proven NASH patients referred to our outpatient Liver Unit were invited to participate and 45 did accept. The diagnosis of NASH was based on the accepted clinico-histological criteria,17 which requires the exclusion of other causes of liver disease, namely alcohol intake >20 g/day, markers of chronic viral infection B and C, α1 antitrypsin deficiency, primary biliary cirrhosis, hemochromatosis, auto-immune hepatitis, and Wilson's disease.
The study was
NASH patients and controls characteristics
General demographic, anthropometric, clinical and key laboratory data from patients and controls are presented in Table 1. Women were prevalent in both groups and mean age was overall 50 years. None of the participants was undernourished; among patients, two (4%) had normal weight, 15 (32%) were overweight, and 28 (64%) were obese. Hypertension, diabetes and dyslipidemia were very common; the prevalence of hypertension was similar in both groups, though the prevalence of diabetes was
Discussion
In this study, we have shown that NASH patients recall a diet richer in fat and poorer in carbohydrates and protein when compared to a large sample of the general population. Unlike Musso et al.15 who reported increased saturated fat consumption, our patients had a higher consumption of monounsaturated fat than controls, however low to recommendations in 82%; study groups were nevertheless very different. Furthermore, in order to study patients as seen in everyday practice, our sample included
References (41)
- et al.
The natural history of nonalcoholic fatty liver: a follow-up tudy
Hepatology
(1995) - et al.
NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States
Hepatology
(2002) - et al.
Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome
Hepatology
(2003) - et al.
Nonalcoholic fatty liver—another feature of the metabolic syndrome?
Clin Nutr
(1999) - et al.
Steatohepatitis: a tale of two “hits”
Gastroenterology
(1998) - et al.
Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities
Gastroenterology
(2001) - et al.
In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases
J Hepatol
(2002) - et al.
Characterization of pathogenic and prognostic factors of nonalcoholic steatohepatitis associated with obesity
J Hepatol
(2000) - et al.
Dietary Reference Intakes: development and uses for assessment of micronutrient status of women—a global perspective
Am J Clin Nutr
(2005) National nutrition and public health policies: issues related to bioavailability of nutrients when developing Dietary Reference Intakes
J Nutr
(2001)
Dietary Reference Intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein and amino acids
J Am Diet Assoc
Steatohepatitis in obese individuals
Best Pract Res Clin Gastroenterol
Old wine in new bottles? The RDA and the RDI
Nutrition
Polyunsaturated fatty acid regulation of gene transcription: a molecular mechanism to improve the metabolic syndrome
J Nutr
The metabolic abnormalities associated with non-alcoholic fatty liver disease
Best Pract Res Clin Gastroenterol
Nonalcoholic steatohepatitis clinicopathological comparison with alcoholic hepatitis in ambulatory and hospitalized patients
Dig Dis Sci
Cryptogenic cirrhosis: Clinical characterization and risk factors for underlying disease
Hepatology
Nonalcoholic fatty liver disease: an underrecognized cause of cryptogenic cirrhosis
JAMA
Etiopathogenesis of nonalcoholic steatohepatitis
Semin Liver Dis
A peroxidação dos lípidos na esteatohepatite não alcoólica: relação com a esteatose
GE-J Port Gastrenterol
Cited by (226)
Dietary composition and its association with metabolic dysfunction-associated fatty liver disease among Chinese adults: A cross-sectional study
2024, Arab Journal of GastroenterologyDietary intake of pregnant women with non-alcoholic fatty liver disease: A case-control study
2023, Clinical Nutrition ESPENAssociation of nutrient intake with non-alcoholic fatty liver disease and liver steatosis in adult Indian population – A case control study
2023, Human Nutrition and MetabolismSystematic Review and Meta-analysis: The Role of Diet in the Development of Nonalcoholic Fatty Liver Disease
2023, Clinical Gastroenterology and HepatologyNon-pharmacological treatment approach in patients with metabolic dysfunction-associated liver disease
2023, Comprehensive Guide to Hepatitis AdvancesNutrition in liver disease
2023, Comprehensive Guide to Hepatitis Advances